![](/img/cover-not-exists.png)
Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
Robichaux, Jacqulyne P., Elamin, Yasir Y., Tan, Zhi, Carter, Brett W., Zhang, Shuxing, Liu, Shengwu, Li, Shuai, Chen, Ting, Poteete, Alissa, Estrada-Bernal, Adriana, Le, Anh T., Truini, Anna, Nilsson,Language:
english
Journal:
Nature Medicine
DOI:
10.1038/s41591-018-0007-9
Date:
April, 2018
File:
PDF, 2.24 MB
english, 2018